Maureen A. Zivanovic

Author

Also Known As

M A Zivanovic, M. A. Zivanovic, M. Zivanovic, M.A. Zivanovic, MAUREEN A. ZIVANOVIC, Maureen A. Zivanovic, Maureen Zivanovic, MaureenA. Zivanovic

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Southampton General Hospital Hampton University University of Manchester Guy's Hospital St James's University Hospital

About

Maureen A. Zivanovic is an author at Southampton General Hospital specializing in medicine, nuclear medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	1.1K
2	Health Sciences	5	5	456
3	Education	2	2	312
4	Engineering	1	1	55
5	Humanities	1	1	14

Maureen A. Zivanovic

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Guidelines for the measurement of glomerular filtration rate using plasma sampling John Fleming, Maureen A. Zivanovic, Glen M. Blake, Nuclear Medicine Communications MeasurementEducationRenal FunctionBiostatisticsClinical Chemistry	2004	298
A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone Valerie Lewington, Alexander McEwan, Duncan Ackery, European Journal of Cancer and Clinical Oncology UrologyHealth SciencesPain MedicineMedicineCancer Management	1991	279
Sr-89 therapy: Strontium kinetics in disseminated carcinoma of the prostate Glen M. Blake, Maureen A. Zivanovic, Alexander McEwan, European Journal of Nuclear Medicine and Molecular Imaging Strontium KineticsUrologyRadiation MedicineMedicineRadiopharmaceutical Therapy	1986	251
Strontium-89 chloride for pain palliation in prostatic skeletal malignancy A. H. Laing, D. M. Ackery, R. J. Bayly, British Journal of Radiology	1991	218
Strontium-89 therapy: measurement of absorbed dose to skeletal metastases. Glen M. Blake, Maureen A. Zivanovic, R. M. Blaquiére, PubMed UrologyRadiation TherapyStrontium-89 TherapyMedicineRadionuclide Therapy	1988	94
Phase 1/2 study of fractionated 131I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy Tim Illidge, Mike Bayne, Nicholas Brown, Blood	2008	87
Fractionated <sup>90</sup>Y-Ibritumomab Tiuxetan Radioimmunotherapy As an Initial Therapy of Follicular Lymphoma: An International Phase II Study in Patients Requiring Treatment According to GELF/BNLI Criteria Tim Illidge, Sam Mayes, Ruth Pettengell, Journal of Clinical Oncology	2013	60
The limitations of the dual radionuclide subtraction technique for the external detection of tumours by radioiodine-labelled antibodies R.J. Ott, Linda Grey, Maureen A. Zivanovic, British Journal of Radiology 99Tcm-labelled HsaEngineeringPathologyRadioiodine-labelled AntibodiesNeuro-oncology	1983	55
A general equation for estimating glomerular filtration rate from a single plasma sample John Fleming, Linda Persaud, Maureen A. Zivanovic Nuclear Medicine Communications	2005	43
Strontium-89 radionuclide therapy: a dosimetric study using impulse response function analysis Glen M. Blake, Jane Gray, Maureen A. Zivanovic, British Journal of Radiology PharmacotherapyStrontium KineticsOncologyDosimetric StudyBrachytherapy	1987	34

Page 1